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Abstract
Introduction: Stenotrophomonas maltophilia is an important cause of hospital acquired infection
particularly among severely debilitated and immunosuppressed patients.
Case presentation: We report a case of S. maltophilia meningitis in a preterm baby boy after a
neurosurgical procedure, successfully treated with trimethoprim-sulfamethoxazole and ciprofloxacin.
Conclusion: Thisorganismshouldbeconsideredas apotentialcauseofmeningitisand trimethoprim-
sulfamethoxazole and ciprofloxacin are a combination that is successful and safe for treating preterm
infants.
Introduction
Stenotrophomonas maltophilia (S. maltophilia) is a non-
fermentative Gram-negative bacillus, previously known as
Pseudomonas maltophilia and later Xanthomonas maltophilia.
This bacterium is found in several environments such as
water, soil, plants, food and hospital settings [1,2]. It is
increasingly recognised as a significant cause of hospital
acquired infection particularly among severely debilitated
and immunosuppressed patients, those receiving long-
term antimicrobial therapy and those with indwelling
central venous catheters. The resultant infections are
extensive, with the respiratory tract, soft tissues and the
skin most frequently involved [1-4]. Although the patho-
genisconsideredtobeaninfrequentcauseofmeningitis,it
has become a focus of interest not only due to increasing
recognition of its pathogenic potential but also because of
its marked antibiotic resistance [1].
Here we report a case of S. maltophilia meningitis in a baby
boy after a neurosurgical procedure, successfully treated
with the combination of trimethoprim-sulfamethoxazole
and ciprofloxacin.
Case presentation
A baby boy was delivered at 26 weeks of gestation after a
spontaneous rupture of membranes. The patient was
admitted to our neonatal intensive care unit with Apgar
scores of two and eight at 1 and 5 minutes, respectively.
Page 1 of 3
(page number not for citation purposes)On the 12th day of his life clinical and radiological signs
of perforated necrotizing enterocolitis (NEC) occurred
and required surgical intestinal resection. Cerebral ultra-
sound at day 15 of his life was performed and showed
intraventricular haemorrhage and dilated cerebral ventri-
cles. Because of NEC, temporary external cerebrospinal
fluid (CSF) drainage was inserted. Two weeks after external
CSF drainage was performed, he developed Klebsiella BLEE
meningitis. Antibiotic therapy with meropenem was
started and the external CSF drainage was replaced. After
19 days of treatment with meropenem a new CSF sample
from drainage revealed 1200 cells/mm
3 (95% neutro-
phils), protein 3.4 g/L and glucose 0.03 g/L. Gram-
negative bacillus were seen on gram strain in the CSF
culture and it was positive for S. maltophilia. The strain
was only susceptible in vitro to trimethoprim-
sulfamethoxazole (TMP-SMX), with a mean inhibitory
concentration (MIC) of ≤2/38, minocycline and cipro-
floxacin. TMP-SMX intravenous therapy (50 mg/kg per
day in two divided doses) was commenced. The external
ventricular drainage was not removed at this stage because
the patient’s state was critical. The next sample analysis of
CSF from the drainage 14 days after starting TMP-SMX
revealed the following profile: white blood cell count of
1300 cells/mm
3 (90% neutrophils), protein 1.39 g/L and
glucose 0.04 g/L. The CSF culture was still positive for
S. maltophilia and consequently ciprofloxacin (15 mg/kg
per day in two divided doses) was added to TMP-SMX.
Furthermore, the external ventricular drainage was
removed and after 7 days of therapy with ciprofloxacin
in combination with TMP-SMX, the analysis of the CSF
was normal and the culture was sterile. Finally, 21 more
days of therapy were completed with both antibiotics. No
adverse effects were found during ciprofloxacin treatment.
There was no displacement of bilirubin with the use
of sulfamethoxazole in our patient and the values
were normal (maximum total bilirubin 1.27 mg/dL). A
ventricular-peritoneal shunt was inserted after the infec-
tion was eradicated due to severe ventricular dilatation.
Discussion
S. maltophilia is an extremely rare cause of meningitis and,
to our knowledge, only 15 cases, including our case, have
been reported to date [2]. Four cases were children
including two neonates with S. maltophilia meningitis.
The median age for the two female and two male infants
was 5.3 months; range from 4 days to 13 months [2-5].
The two previous patients with neonatal S. maltophilia
meningitis were preterm infants and were 4 and 7 days
old, respectively. One patient died immediately after
presentation and the other one was successfully treated
with ciprofloxacin because of multi-resistant S. maltophilia
(Table 1).
The reported risk factors associated with S. maltophilia
infection are prematurity, neurosurgical procedures (espe-
cially shunts and drainages), intracranial haemorrhages
and malignancies [6]. Our patient had undergone several
neurosurgical procedures and also, importantly, had been
treated with a previous broad-spectrum antibiotic such as
carbapenem, which is also a suggested risk factor for
infection with S. maltophilia [1,6].
S. maltophilia is increasingly recognised as a cause of noso-
comial infections of special interest because of its intrinsic
resistance to multiple antimicrobial agents used to treat
Gram-negative infections. It is resistant to a variety of
antibiotics, for example aminoglycosides, ß-lactam agents
and it is intrinsically resistant to carbapenems. Based on
susceptibility studies, TMP-SMX is the drug of choice for
treatment of S. maltophilia infections. However, recent data
indicate that the percentage of strains resistant to TMP-
SMX may be increasing [1,3,7,8]. In this patient the
pathogen was susceptible to this antimicrobial therapy but
CSF cultures only became sterile after removal of the
external ventricular drainage and the addition of cipro-
floxacin to TMP-SMX. We decided to add ciprofloxacin
because TMP-SMX is bacteriostatic and the infant was
seriously ill. The administration of sulfamethoxazole,
which binds to albumin and competes with bilirubin,
can increase the possibility of hyperbilirubinaemia and
serious neurological complications such as kernicterus in
neonates. This was not observed in our patient.
With respect to ciprofloxacin, the optimal dose and
duration of the treatment for neonatal Gram-negative
meningitis remains uncertain. Lo et al. reported a preterm
infant with multi-resistant S. maltophilia (including resis-
tance to TMP-SMX) meningitis successfully treated with
ciprofloxacin [3]. Due to the small number of cases and
the short follow-up periods, further studies are needed to
establish dosage, CSF ciprofloxacin concentrations and
duration of treatment for meningitis. There is also very
little information available on this drug sequelae [3,7,8].
Table 1. Details of children with meningitis caused by S. maltophilia
Case No Reference/Year Age/sex Neurosurgical procedure Therapy Outcome
1 (1) 1977 8 months/male None Ampicilin, colistin Died
2 (1) 1977 13 months/ female None Chloramphenicol, sulphadoxine Recovered
3 (2) 1984 7 days/male None None Died
4 (3) 2002 4 days/female None Ciprofloxacin Recovered
5 Present report 69 days/male External (CSF) drainage TMP-SMX, ciprofloxacin Recovered
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Journal of Medical Case Reports 2009, 3:7389 http://jmedicalcasereports.com/jmedicalcasereports/article/view/7389The severe ventricular dilatation in our patient was due to
intraventricular haemorrhageand thehearing deficit noted
could be a consequence of meningitis. Long-term follow-
up, including routine neurologic examination as well as
visual and auditory evoked potentials, is obligatory. Our
patient is the first case of S. maltophilia meningitis in a
preterm infant successfully treated with the antimicrobial
combination of TMP-SMX and ciprofloxacin.
Conclusions
Due to the increase in meningitis caused by S. maltophilia
in neurosurgical cases, and its marked resistance to
antibiotics normally used to treat Gram-negative nosoco-
mial infections, it should be considered as a potential
cause of meningitis in patients with external ventricular
drainage and long-term broad-spectrum antimicrobial
therapy.
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